Presentation TVT 2022 Exercise PVR, A Key Predictor of Benefit of Atrial Shunt Therapy in HFpEF? Presenter: Sanjiv Shah June 10, 2022
Presentation TVT 2022 What (Else) Have We Learned From REDUCE-LAP II? Presenter: Sanjiv Shah June 10, 2022
News Daily News ESC Heart Failure 2022 SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH Shelley Wood May 22, 2022
News Industry News Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients February 02, 2022
News Conference News THT 2022 REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF Shelley Wood February 01, 2022
Presentation THT 2022 Current status of the REBALANCE-HF US FDA randomized feasibility clinical trial in HFpEF Presenter: Sanjiv Shah February 01, 2022
Presentation THT 2022 Long-term follow-up on FIH experience using the Satera Ablation System in HFpEF and HFrEF Presenter: Sanjiv Shah February 01, 2022
Presentation THT 2022 REDUCE LAP-HF II Randomized Study of the Corvia Atrial Shunt -- Primary Results Presenter: Sanjiv Shah February 01, 2022
Presentation THT 2022 CON - PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's! Presenter: Sanjiv Shah February 01, 2022
Presentation TVT 2021 Who Are the Ideal Patients for an IASD: HFpEF, HFrEF, RCM, and Beyond… Presenter: Sanjiv J. Shah July 22, 2021
News Industry News Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt November 17, 2020
News Conference News HFSA 2020 Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study L.A. McKeown October 12, 2020
News Industry News Corvia Medical Announces Strong Positive One-Year Data From Reduce LAP-HF I Randomized, Sham-Controlled Clinical Trial August 27, 2018
News Conference News AHA 2017 Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I Michael O'Riordan November 21, 2017